Literature DB >> 3129826

Endothelium-dependent contractions to calcium ionophore A23187, arachidonic acid, and acetylcholine in canine basilar arteries.

Z S Katusic1, J T Shepherd, P M Vanhoutte.   

Abstract

The effects of the calcium ionophore A23187, arachidonic acid, and acetylcholine were studied in isolated canine basilar arteries. Rings with and without endothelium were suspended for isometric tension recording in physiological saline. In unstimulated rings, A23187, arachidonic acid, and acetylcholine caused endothelium-dependent contractions. The contractions of rings caused by uridine 5'-triphosphate were not affected by removal of the endothelium. An inhibitor of cyclooxygenase, indomethacin (10(-5) M), prevented excitatory responses to A23187, arachidonic acid, and acetylcholine but did not alter contractions caused by KCl. An inhibitor of thromboxane synthetase, dazoxiben (10(-4) M), significantly reduced endothelium-dependent contractions to A23187 and arachidonic acid but did not significantly affect contractions caused by acetylcholine. These results demonstrate that A23187, arachidonic acid, and acetylcholine cause excitatory endothelium-dependent responses in canine cerebral blood vessels by increasing the release of product(s) of cyclooxygenase from endothelial cells; in the case of A23187 and arachidonic acid, thromboxane A2 contributes to the endothelium-dependent contractions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129826     DOI: 10.1161/01.str.19.4.476

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  20 in total

Review 1.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 2.  Vasoconstrictor prostanoids.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-03-24       Impact factor: 3.657

Review 3.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

Review 4.  Endothelium-dependent contractions in hypertension.

Authors:  Paul M Vanhoutte; Michel Feletou; Stefano Taddei
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

5.  The calcium ionophore A23187 induces endothelium-dependent contractions in femoral arteries from rats with streptozotocin-induced diabetes.

Authors:  Y Shi; M Feletou; D D Ku; R Y K Man; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

Review 6.  Endothelium-dependent contractions: when a good guy turns bad!

Authors:  Paul M Vanhoutte; Eva H C Tang
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

7.  Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age.

Authors:  Gautam Sikka; Karen L Miller; Jochen Steppan; Deepesh Pandey; Sung M Jung; Charles D Fraser; Carla Ellis; Daniel Ross; Koenraad Vandegaer; Djahida Bedja; Kathleen Gabrielson; Jeremy D Walston; Dan E Berkowitz; Lili A Barouch
Journal:  Exp Gerontol       Date:  2012-11-13       Impact factor: 4.032

8.  HN-10200 causes endothelium-independent relaxations in isolated canine arteries.

Authors:  F Cosentino; A Schirger; Z S Katusić
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

9.  Hypertension and the absence of EDHF-mediated responses favour endothelium-dependent contractions in renal arteries of the rat.

Authors:  F S Michel; G S Man; R Y K Man; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

10.  Acidosis prevents and alkalosis augments endothelium-dependent contractions in mouse arteries.

Authors:  Oliver Baretella; Aimin Xu; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2013-07-20       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.